BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 8976232)

  • 61. Videourodynamic evaluation of urge syndrome following pubovaginal sling procedure for stress urinary incontinence in women.
    Chuang FC; Kuo HC
    Int Urogynecol J Pelvic Floor Dysfunct; 2009 Oct; 20(10):1253-8. PubMed ID: 19495534
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Pubovaginal sling: 4-YEAR outcome analysis and quality of life assessment.
    Morgan TO; Westney OL; McGuire EJ
    J Urol; 2000 Jun; 163(6):1845-8. PubMed ID: 10799196
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Results of pubovaginal sling for the treatment of intrinsic sphincteric deficiency determined by questionnaire analysis.
    Haab F; Trockman BA; Zimmern PE; Leach GE
    J Urol; 1997 Nov; 158(5):1738-41. PubMed ID: 9334590
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Expanded indications for the pubovaginal sling: treatment of type 2 or 3 stress incontinence.
    Zaragoza MR
    J Urol; 1996 Nov; 156(5):1620-2. PubMed ID: 8863552
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Pubovaginal fascial sling for the treatment of complicated stress urinary incontinence.
    Blaivas JG; Jacobs BZ
    J Urol; 1991 Jun; 145(6):1214-8. PubMed ID: 2033696
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Short-term complications of pubovaginal sling procedure for genuine stress incontinence in women.
    Chan PT; Fournier C; Corcos J
    Urology; 2000 Feb; 55(2):207-11. PubMed ID: 10688080
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The surgical results of the pubovaginal sling procedure using Intravaginal Slingplasty (IVS) for stress urinary incontinence.
    Basok EK; Yildirim A; Atsu N; Gurbuz C; Tokuc R
    Int Urol Nephrol; 2006; 38(3-4):507-12. PubMed ID: 17318357
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Age is not a limiting factor for midurethral sling procedures in the elderly with urinary incontinence.
    Ku JH; Oh JG; Shin JW; Kim SW; Paick JS
    Gynecol Obstet Invest; 2006; 61(4):194-9. PubMed ID: 16465064
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Voiding dysfunction following removal of eroded synthetic mid urethral slings.
    Starkman JS; Wolter C; Gomelsky A; Scarpero HM; Dmochowski RR
    J Urol; 2006 Sep; 176(3):1040-4. PubMed ID: 16890687
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Intermediate term failure of pubovaginal slings using cadaveric fascia lata: a case series.
    O'Reilly KJ; Govier FE
    J Urol; 2002 Mar; 167(3):1356-8. PubMed ID: 11832731
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Results in 32 women operated for genuine stress incontinence with the pubovaginal sling procedure ad modum Ed McGuire.
    Borup K; Nielsen JB
    Scand J Urol Nephrol; 2002; 36(2):128-33. PubMed ID: 12028686
    [TBL] [Abstract][Full Text] [Related]  

  • 72. A retrospective multicenter study on outcomes after midurethral polypropylene sling revision for voiding dysfunction.
    Molden S; Bracken J; Nguyen A; Harvie HS; White A; Hammil SL; Patterson D; Tarr M; Sanses T; Murphy M; Rogers RG
    Female Pelvic Med Reconstr Surg; 2010 Nov; 16(6):340-4. PubMed ID: 22453618
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Bladder outlet obstruction after pubovaginal fascial sling.
    Toledo LG; Korkes F; Romero FR; Fernandes RC; Oliveira C; Perez MD
    Int Urogynecol J Pelvic Floor Dysfunct; 2009 Feb; 20(2):201-5. PubMed ID: 19002645
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The use of porcine dermal implant in a minimally invasive pubovaginal sling procedure for genuine stress incontinence.
    Barrington JW; Edwards G; Arunkalaivanan AS; Swart M
    BJU Int; 2002 Aug; 90(3):224-7. PubMed ID: 12133056
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Ultra Long-term Follow-up of the Autologous Pubovaginal Sling for Stress Incontinence: Results at 23 Years.
    Zaragoza MR; Moorman M; Chew L
    Urology; 2024 Mar; 185():44-48. PubMed ID: 38101581
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Risk Factor of De Novo Urgency and Urge Incontinence After Autologous Fascia Pubovaginal Sling.
    Yang PS; Delpe S; Kowalik CG; Reynolds WS; Kaufman MR; Dmochowski RR
    Res Rep Urol; 2021; 13():591-596. PubMed ID: 34422706
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Pubovaginal slings: past, present and future.
    Sarver R; Govier FE
    Int Urogynecol J Pelvic Floor Dysfunct; 1997; 8(6):358-68. PubMed ID: 9609336
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The correction of type 2 stress incontinence with a polytetrafluoroethylene patch sling: 5-year mean followup.
    Yamada T; Arai G; Masuda H; Tsukamoto T; Nagahama K; Nagamatsu H
    J Urol; 1998 Sep; 160(3 Pt 1):746-9. PubMed ID: 9720537
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Use of synthetic material in sling surgery: a minimally invasive approach.
    Norris JP; Breslin DS; Staskin DR
    J Endourol; 1996 Jun; 10(3):227-30. PubMed ID: 8740383
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Long-term outcome and quality of life after modified pubovaginal sling for intrinsic sphincteric deficiency.
    Hassouna ME; Ghoniem GM
    Urology; 1999 Feb; 53(2):287-91. PubMed ID: 9933041
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.